Cellares announced strategic partnerships aimed at expanding capabilities of its Cell Q platform, an automated, high-throughput quality control system designed to meet commercial-scale cell therapy manufacturing demands. Integrations with providers such as Tecan and Cytek Biosciences enable streamlined liquid handling, flow cytometry, and real-time data tracking. Cell Q promises to efficiently support up to 6,000 cell therapy batch releases annually, addressing bottlenecks in traditional manual QC and facilitating scalable and reproducible therapy production workflows.